Vol 55, No 2 (2024)
Clinical vignette
Published online: 2024-03-01

open access

Page views 236
Article views/downloads 143
Get Citation

Connect on Social Media

Connect on Social Media

Allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia with an accompanying hereditary hemorrhagic telangiectasia

Daniel Habraszka1, Szymon Gawęda1, Adrianna Spałek2, Grzegorz Helbig2
Acta Haematol Pol 2024;55(2):123-125.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. McDonald J, Bayrak-Toydemir P, Pyeritz RE. Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis. Genet Med. 2011; 13(7): 607–616.
  2. Sadick H, Riedel F, Naim R, et al. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression. Haematologica. 2005; 90(6): 818–828.
  3. Viteri-Noël A, González-García A, Patier JL, et al. Hereditary hemorrhagic telangiectasia: genetics, pathophysiology, diagnosis, and management. J Clin Med. 2022; 11(17): 5245.
  4. Shovlin C, Guttmacher A, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). American Journal of Medical Genetics. 2000; 91(1): 66–67, doi: 10.1002/(sici)1096-8628(20000306)91:1<66::aid-ajmg12>3.0.co;2-p.
  5. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med. 1999; 245(1): 31–39.
  6. Letteboer TGW, Mager JJ, Snijder RJ, et al. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet. 2006; 43(4): 371–377.
  7. Williams JCB, Hamilton JK, Shiller M, et al. Combined juvenile polyposis and hereditary hemorrhagic telangiectasia. Proc (Bayl Univ Med Cent). 2012; 25(4): 360–364.
  8. Mazharian A, Ghevaert C, Zhang L, et al. Dasatinib enhances megakaryocyte differentiation but inhibits platelet formation. Blood. 2011; 117(19): 5198–5206.
  9. Sartor C, Papayannidis C, Chiara Abbenante M, et al. Recurrent gastrointestinal hemorrhage in treatment with dasatinib in a patient showing SMAD4 mutation with acute lymphoblastic leukemia Philadelphia positive and juvenile polyposis hereditary hemorrhagic telangiectasia syndrome. Hematol Rep. 2013; 5(2): 26–27.